Deutsche Bank Cuts Harmony Biosciences Price Target to $38, Keeps Hold Rating
Deutsche Bank lowered its price target from $42 to $38 and maintained its Hold rating on Harmony Biosciences.
Deutsche Bank lowered its price target from $42 to $38 and maintained its Hold rating on Harmony Biosciences.